Back
PT Pakuwon Jati Tbk Vs. Celldex Therapeutics, Inc. Industry Stock Comparison
Sell
35
PTPKF
PT Pakuwon Jati Tbk
Last Price:
$0.0191
Seasonality Move:
622.22%
Sell
48
CLDX
Celldex Therapeutics, Inc.
Last Price:
$31.05
Seasonality Move:
20.93%
Sell
35
PT Pakuwon Jati Tbk (PTPKF)
is a Sell
Is PT Pakuwon Jati Tbk a Buy, Sell or Hold?
-
The current PT Pakuwon Jati Tbk [PTPKF] share price is $0.0191. The Score for PTPKF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
PTPKF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTPKF Stock Price Chart
What is PT Pakuwon Jati Tbk's stock price today?
-
The PT Pakuwon Jati Tbk share price today is $0.0191Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTPKF is experiencing slight buying pressure.
CLDX Stock Price Chart
What is Celldex Therapeutics, Inc.'s stock price today?
-
The Celldex Therapeutics, Inc. share price today is $31.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTPKF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 34.72 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0191 - 0.0191) | Sell |
| Bollinger Bands (100): | (0.0137 - 0.0337) | Sell |
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 55.97 | Buy |
| Chaikin Money Flow: | 3988094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.43 - 31.31) | Buy |
| Bollinger Bands (100): | (24.48 - 29.54) | Buy |
PTPKF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Sell |
| 20-day SMA: | 0.02 | Sell |
| 50-day SMA: | 0.02 | Sell |
| 200-day SMA: | 0.05 | Sell |
| 8-day EMA: | 0.02 | Buy |
| 20-day EMA: | 0.01 | Buy |
| 50-day EMA: | 0.01 | Buy |
| 200-day EMA: | 0 | Buy |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.05 | Buy |
| 20-day SMA: | 30.57 | Buy |
| 50-day SMA: | 27.66 | Buy |
| 200-day SMA: | 25.4 | Buy |
| 8-day EMA: | 30.94 | Buy |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.67 | Buy |
| 200-day EMA: | 26.26 | Buy |
PT Pakuwon Jati Tbk Earnings Growth & PTPKF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.
PT Pakuwon Jati Tbk Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celldex Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||